اخبار بازار

آخرین اخبار مالی و اقتصادی، تحولات بازار، گزارش‌ها و تحلیل‌های بازارهای مالی را در PipVero دنبال کنید.

منبع: Newsfile Corp خبرگزاری
یک ماه پیش
سهام اهمیت متوسط
ROSEN, REGARDED INVESTOR COUNSEL, Encourages PennyMac Financial Services, Inc. Investors to Inquire About Securities Class Action Investigation - PFSI

ROSEN, REGARDED INVESTOR COUNSEL, Encourages PennyMac Financial Services, Inc. Investors to Inquire About Securities Class Action Investigation - PFSI

New York, New York--(Newsfile Corp. - August 6, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of PennyMac Financial Services, Inc. (NYSE: PFSI) resulting from allegations that PennyMac may have issued materially misleading business information to the investing public. SO WHAT: If you purchased PennyMac securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

نمادهای مرتبط 1
PFSI PFSI
منبع: Newsfile Corp
مشاهده منبع
نظر
منبع: Newsfile Corp خبرگزاری
یک ماه پیش
سهام اهمیت متوسط
ROSEN, GLOBAL INVESTOR RIGHTS COUNSEL, Encourages Elauwit Connection, Inc. Investors to Inquire About Securities Class Action Investigation - ELWT

ROSEN, GLOBAL INVESTOR RIGHTS COUNSEL, Encourages Elauwit Connection, Inc. Investors to Inquire About Securities Class Action Investigation - ELWT

New York, New York--(Newsfile Corp. - August 6, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Elauwit Connection, Inc. (NASDAQ: ELWT) resulting from allegations that Elauwit may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Elauwit securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

نمادهای مرتبط 1
ELWT ELWT
منبع: Newsfile Corp
مشاهده منبع
نظر
منبع: Zacks Investment Research خبرگزاری
یک ماه پیش
سهام اهمیت متوسط
ICU Medical (ICUI) Tops Q2 Earnings and Revenue Estimates

ICU Medical (ICUI) Tops Q2 Earnings and Revenue Estimates

ICU Medical (ICUI) came out with quarterly earnings of $2.37 per share, beating the Zacks Consensus Estimate of $1.91 per share. This compares to earnings of $2.1 per share a year ago.

نمادهای مرتبط 1
ICUI ICUI
منبع: Zacks Investment Research
مشاهده منبع
نظر
منبع: Zacks Investment Research خبرگزاری
یک ماه پیش
سهام اهمیت متوسط
Onto Innovation (ONTO) Q2 Earnings and Revenues Beat Estimates

Onto Innovation (ONTO) Q2 Earnings and Revenues Beat Estimates

Onto Innovation (ONTO) came out with quarterly earnings of $1.93 per share, beating the Zacks Consensus Estimate of $1.68 per share. This compares to earnings of $1.25 per share a year ago.

نمادهای مرتبط 1
ONTO ONTO
منبع: Zacks Investment Research
مشاهده منبع
نظر
منبع: Zacks Investment Research خبرگزاری
یک ماه پیش
سهام اهمیت متوسط
Morgan Stanley Direct Lending Fund (MSDL) Surpasses Q2 Earnings and Revenue Estimates

Morgan Stanley Direct Lending Fund (MSDL) Surpasses Q2 Earnings and Revenue Estimates

Morgan Stanley Direct Lending Fund (MSDL) came out with quarterly earnings of $0.45 per share, beating the Zacks Consensus Estimate of $0.44 per share. This compares to earnings of $0.5 per share a year ago.

نمادهای مرتبط 1
MSDL MSDL
منبع: Zacks Investment Research
مشاهده منبع
نظر
منبع: Zacks Investment Research خبرگزاری
یک ماه پیش
سهام اهمیت متوسط
Mach Natural Resources LP (MNR) Q2 Earnings and Revenues Beat Estimates

Mach Natural Resources LP (MNR) Q2 Earnings and Revenues Beat Estimates

Mach Natural Resources LP (MNR) came out with quarterly earnings of $0.38 per share, beating the Zacks Consensus Estimate of $0.34 per share. This compares to earnings of $0.76 per share a year ago.

نمادهای مرتبط 1
MNR MNR
منبع: Zacks Investment Research
مشاهده منبع
نظر
منبع: Zacks Investment Research خبرگزاری
یک ماه پیش
سهام اهمیت متوسط
Inogen (INGN) Reports Q2 Loss, Tops Revenue Estimates

Inogen (INGN) Reports Q2 Loss, Tops Revenue Estimates

Inogen (INGN) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to a loss of $0.15 per share a year ago.

نمادهای مرتبط 1
INGN INGN
منبع: Zacks Investment Research
مشاهده منبع
نظر